Zhang, Yu
Zhang, Qilei
Wu, Xinyang
Wu, Geping http://orcid.org/0000-0002-7194-0716
Ma, Xingkai
Cheng, Lei
Article History
Received: 1 June 2022
Accepted: 1 July 2022
First Online: 13 July 2022
Declarations
:
: The authors declare that they have no conflict of interest.
: The study was approved by the research committee of Zhangjiagang Hospital affiliated to Soochow University, China. Bicalutamide, an androgen receptor antagonist, effectively alleviate allergic rhinitis via suppression of PI3K–PKB activity.